Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic initiated the recall of certain Pipeline Vantage embolisation devices in January 2025 following reports of four ...

Of the 22 guru strategies we follow, MDT rates highest using our Multi-Factor Investor model based on the published strategy of Pim van Vliet. This multi-factor model seeks low volatility stocks ...

TVA has a distinct opportunity to become the testbed for cutting-edge energy solutions, and Tennessee cannot drive innovation ...

For its Pipeline Vantage 021 models, Medtronic is updating the instructions for use. And for the Pipeline Vantage 027 model, the company is asking doctors to return them, the agency said.

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the ... solutions for specific applications. MTD is a #3 (Hold) on the Zacks Rank ...

U.S. Meetings, Incentives, Conferences and Exhibitions Market78 CA, UNITED STATES, March 20, 2025 /EINPresswire / -- The latest report from Co ...

Medtronic has recalled embolization devices collectively linked to reports of 17 injuries and four deaths, the Food and Drug Administration said Tuesday. The recall has two elements: Medtronic is ...